| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +3,823 | +8.9% | $0.000000 | 46,598 | 25 Feb 2022 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | $192,209 | -837 | -1.8% | $229.64 | 45,761 | 25 Feb 2022 | Direct | F2 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | $348,134 | -1,516 | -3.3% | $229.64 | 44,245 | 25 Feb 2022 | Direct | F3 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | $527,611 | -2,307 | -5.2% | $228.70 | 41,938 | 28 Feb 2022 | Direct | F4 |
| holding | CI | Common Stock, $.01 Par Value | 1,337 | 25 Feb 2022 | By 401(k) | F5 |
| Id | Content |
|---|---|
| F1 | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2019-2021 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| F2 | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| F3 | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| F4 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021. |
| F5 | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |